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Impact of Long-Wavelength UVA and Visible Light on
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Bassel H. Mahmoud1, Eduardo Ruvolo2, Camile L. Hexsel1, Yang Liu2,3, Michael R. Owen1,
Nikiforos Kollias2, Henry W. Lim1 and Iltefat H. Hamzavi1
The purpose of this study was to determine the effect of visible light on the immediate pigmentation and
delayed tanning of melanocompetent skin; the results were compared with those induced by long-wavelength
UVA (UVA1). Two electromagnetic radiation sources were used to irradiate the lower back of 20 volunteers with
skin types IV–VI: UVA1 (340–400nm) and visible light (400–700 nm). Pigmentation was assessed by visual
examination, digital photography with a cross-polarized filter, and diffused reflectance spectroscopy at 7 time
points over a 2-week period. Confocal microscopy and skin biopsies for histopathological examination using
different stains were carried out. Irradiation was also carried out on skin type II. Results showed that although
both UVA1 and visible light can induce pigmentation in skin types IV–VI, pigmentation induced by visible light
was darker and more sustained. No pigmentation was observed in skin type II. The quality and quantity of
pigment induced by visible light and UVA1 were different. These findings have potential implications on the
management of photoaggravated pigmentary disorders, the proper use of sunscreens, and the treatment of
depigmented lesions.
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INTRODUCTION
Electromagnetic radiation exists as a spectrum. It is classified
based on its wavelength into radio waves, microwaves,
infrared (IR), visible light, UV, X-rays, and g radiation. Studies
on human photobiology have focused primarily on UV
radiation, and more recently, on IR (Schieke et al., 2003). The
visible spectrum, used for general illumination, is defined as
the portion of electromagnetic radiation visible to the human
eye, which corresponds to wavelengths from 400 to 700 nm
(Diffey and Kochevar, 2007). The absorption of visible light
by chromophores in the skin is the principle for its use in laser
therapy, intense pulse light therapy, and photodynamic
therapy. However, the effect of visible light on pigmentary
alterations has not been explored. This is especially relevant,
as the visible spectrum comprises 38.9% of sunlight when it
reaches the surface of the earth (Frederick et al., 1989).
The limited information on visible light is partly due to the
lack of readily available broad-spectrum light source that
emits only in the visible spectrum without UV or IR
components. In this study, we evaluated the effects of a light
source that emits 98.3% visible light on cutaneous pigmen-
tary alterations in individuals with Fitzpatrick skin types
IV–VI, and compared these effects with those induced by
UVA1 (340–400 nm). Furthermore, because it is known that
responses to electromagnetic radiation in the UV range differ
in individuals with different skin types (Jackson, 2003), the
results obtained were compared with those in individuals
with skin type II.
RESULTS
The spectral irradiance of the visible light source used in this
study is shown in Figure 1; the dose range used is shown in
Table 1. The UVA1 light source’s spectral distribution was as
follows: 99.7% of UVA1, 0.12% of UVA2, and 0.17% of
visible light, and less than 0.00001% of UVB radiation. This
made the effects of visible light, UVA2, and UVB radiation
negligible because the highest UVA1 dose used in this study
was 60 J cm2. The visible light source emitted 0.19% UVA1
(340–400 nm), 98.3% visible light (400–700 nm), and 1.5% IR
(700–1800nm) radiation. Considering that the highest dose
for the visible light used in this study was 480 J cm2, there
was less than 1 J cm2 of UVA1 emitted.
Effects of long-wavelength UVA1 (340–400nm) on skin types
IV–VI
The lowest dose at which pigmentation developed for all
patients was 5 J cm2; as the dose was increased, darker
pigmentation was observed. Pigmentation was more intense
in volunteers with darker skin, and was still evident after
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diascopy, suggesting that the observed skin darkening was
indeed due to pigmentary alteration rather than dilatation
of cutaneous vasculature. The immediate pigmentation was
characterized by being well defined and grayish in color
(Figure 2a). With time, the skin color changed to brown and
faded rapidly over the course of 2 weeks following
irradiation. No erythema was observed at any time point
following irradiation.
The diffuse reflectance spectroscopy (DRS) results for oxy-
hemoglobin level and melanin content after irradiation with the
UVA1 light source were analyzed and graphed. The assess-
ment of oxy-hemoglobin levels is a reflection of erythema
clinically, whereas the measurement of melanin content
reflects cutaneous pigmentation. There was no dose–response
or time-course relationship between UVA1 radiation and
oxy-hemoglobin levels assessed using DRS; this finding
correlated with our clinical observation of no erythema
induced by UVA1 irradiation. In contrast, there was a
dose–response correlation between the melanin content and
the UVA1 dose delivered at all of the time points studied,
corresponding to pigmentation observed clinically.
Confocal microscopy did not show any significant
difference in melanocyte density or in the amount of melanin
between irradiated and non-irradiated control sites.
Effects of visible light (400–700 nm) on skin types IV–VI
Immediately after visible light irradiation, there was an
induction of immediate pigmentation; the lowest dose at
which pigmentation developed was 40 J cm2. As the dose was
increased, pigmentation became darker (Figure 2b). Similar to
the results of UVA1, pigmentation was still evident after
diascopy and more intense in skin type V volunteers. However,
in contrast to the UVA1 effect, the immediate pigmentation was
characterized by being dark brown from the start and
surrounded by ill-defined erythema, which disappeared in less
than 2hours. Furthermore, pigmentation induced by visible
light was sustained during the 2-week period of the study and
did not fade away even at lower doses.
DRS results for oxy-hemoglobin and melanin after
irradiation with the visible light source are illustrated in
Figures 3 and 4, respectively. DRS findings showed a direct
correlation between the concentration of oxy-hemoglobin
and the visible light doses delivered, which correlates
with the clinical finding that the higher the dose, the more
intense the erythema (Figure 3). The threshold for a minimal
perceptible erythema, based on clinical observation and
correlation with DRS measurements, is approximately 0.45 in
terms of relative difference in absorbance values (irradiated
minus control sites). As shown in Figure 3, only the two
highest doses, 320 and 480 J cm2, have values consistently
above 0.45 for time points from immediately after exposure
(0 hour) to 2 hours, which correlate with erythema observed
clinically (Figure 2b). After 2 hours, even at 480 J cm2,
oxy-hemoglobin levels dropped to less than 0.45, consistent
with the clinical observation that the erythema was resolved
beyond the 2-hour time point. DRS data show that the
increase in melanin content was directly related to the dose
delivered (Figure 4). For all the doses studied, the melanin
contents at 1 day after irradiation were lower than those at
the earlier time points; this difference was statistically
significant for 160 and 320 J cm2 (Po0.05) doses. At
1 week and 2 weeks after irradiation, for all the doses
studied, melanin contents increased above the levels
observed at the 1-day time point. This DRS-measured
decrease at 24 hours corresponds clinically to the transitional
zone between persistent pigment darkening and delayed
tanning due to new melanin formation.
Confocal microscopy performed following the highest
dose (480 J cm2) at 2 and 24 hours after irradiation showed
redistribution of pigment, in the form of migration of melanin
from basal cells to the upper epidermal cell layers, in the
irradiated site compared with control.
Histopathological results
The histopathological examination carried out following
exposure to the highest dose (480 J cm2) of visible light at
24 hours after irradiation showed no difference between
irradiated and non-inrradiated control sites when stained with
hematoxylin and eosin, Acid Orcein, or P53 stains. Specifi-
cally, no thermal or actinic damage was observed in the
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Figure 1. Spectral irradiance of the visible light source. Note that the vertical
axis is in logarithmic scale.
Table 1. Irradiation doses and fluence rates
Visible light UVA1
Fluence rate: 200mWcm2 Fluence rate: 25mWcm2
Dose (J cm2) Dose (J cm2)
8 1
40 5
80 10
160 20
320 40
480 60
Abbreviation: UVA1, long-wavelength ultraviolet A.
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dermis of the irradiated skin. On the other hand, using the
Fontana–Mason stain, there was a redistribution of melanin
pigment. This means that in the non-irradiated control site,
the pigment was seen just in the basal keratinocytes; whereas
in the irradiated site the pigment was redistributed into the
keratinocytes in the upper spinous cell layers (Figure 5).
Effects of UVA1 and visible light on skin type II
In contrast to pigmentation induced in individuals with skin
types IV–VI, no pigmentation was induced in subjects with
skin type II using the same light sources of UVA1 and visible
light as well as the same doses that were used for volunteers
with skin types IV–VI (Figure 6). DRS results also confirmed
our clinical observation, for there was no significant differ-
ence between oxy-hemoglobin and melanin concentration
measured at the irradiated site compared with the control site
in subjects with skin type II.
DISCUSSION
Studies on cutaneous pigmentary changes have focused
primarily on UV radiation, especially UVA. Whereas visible
light has been used extensively in laser therapy, intense pulse
light therapy, and photodynamic therapy, very little is known
about its effect on the time course and quality of pigmen-
tation, and its effect on different skin types. Furthermore, the
majority of studies done on the effect of UV have focused
on Caucasian population. Population statistics in the United
States show significantly changing demographics in the
past decade. According to the 2000 census, 29% of the
United States population, representing approximately 85
million people, are individuals of color (Taylor and
Cook-Bolden, 2002).
In 1983, Kollias and Baqer (1984) conducted an in vivo
study on the changes in pigmentation induced by visible and
near-IR light using a polychromatic light source of
390–1,700 nm. They observed that pigmentation could occur
without significant UV component. Porges et al. (1988)
exposed 20 healthy individuals with skin types II, III, and IV
to a visible light source of a compact 150-W xenon-arc solar
simulator, with a spectral distribution between 385 and
690nm. Both IPD and immediate erythema faded over a
24-hour period. The residual tanning response remained
unchanged for the remaining 10-day observation period.
The threshold dose for IPD with visible light was between 40
and 80 J cm2, whereas the threshold dose for delayed
tanning was closer to 80–120 J cm2. Owing to the lack of
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Figure 3. Oxy-hemoglobin concentration. Oxy-hemoglobin concentration,
as measured using DRS, at sites irradiated with visible light radiation
(8–480 J cm2) and with measurements taken immediately after irradiation
(0minutes) to 2 weeks later. Oxy-hemoglobin values higher than 0.45
correspond to visually perceptible erythema. Values represent the average
difference between the irradiated and control site values of 20 healthy
volunteers having skin types IV–VI. Error bars denote standard error.
Figure 2. Clinical appearance of irradiated sites immediately after exposure. (a) Six photos showing sites irradiated with UVA1 at doses of 1, 5, 10, 15, 20, 40,
and 60 J cm2, respectively, as indicated in the figure; (b) six photos showing sites irradiated with visible light at doses of 8, 40, 80, 160, 320, and 480 J cm2,
respectively, as indicated in the figure.
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standardization pertaining to the spectrum of visible light
producing sources in the aforementioned two studies, it is
difficult to compare the results. The filter used in the latter
study was a 3-mm Schott GG385 (Schott Optical Company,
Duryea, PA), which should have removed most of the
short-wavelength UV radiation; however, a part of the long
UVA spectrum, together with visible light, was still present in
this filtered light source.
In our study, a light source emitting 98.3% visible light
was used to evaluate the effect of visible light on skin. In
addition, melanocompetent volunteers with skin types IV–VI
were used, which are different from the samples evaluated in
the aforementioned studies. The results obtained for skin
types IV–VI were then compared with those obtained for skin
type II. Although there was evident pigmentation following
UVA1 and visible light irradiation with threshold doses of 5
and 40 J cm2, respectively, no pigmentation was induced on
skin type II for all doses used and at all the time points studied
(Figure 6). These results were also confirmed by DRS, which
objectively assess the degree of pigmentation in skin.
When comparing the quality of pigmentation observed
following UVA1 and visible light irradiation in skin types
IV–VI, it was noted that pigmentation induced by UVA1 was
initially gray in color and then turned brown after 24 hours,
whereas pigmentation induced by visible light was dark
brown from the start (Figure 6). Also, UVA1-induced
pigmentation was well defined and not surrounded by
erythema at any point of time. This was confirmed by DRS,
which showed no increase in the levels of oxy-hemoglobin
at any point of time following irradiation. On the other
hand, following exposure to visible light, erythema appeared
immediately after irradiation surrounding the pigmentation. It
started to fade after half an hour and completely disappeared
2 hours after irradiation (Figure 6).
The light source used in this study had three KG5/3mm
filters to block IR radiation, which generates heat. Therefore,
only a minimal IR component (1.5%) was detected (Figure 1).
It is possible that the erythema following visible light
irradiation in skin types IV–VI is due to the fact that heat is
produced within melanocompetent skin from the absorption
of visible light by melanin pigment. Heat in turn can lead to
dilatation of deep dermal vessels. In this scenario, the heat
generated would be independent of the heat in the light
source; however, it would depend on the concentration of
the melanin chromophore and the amount of visible light
delivered to the skin. This could be the reason why no skin
response was seen in subjects with skin type II.
Pigmentation induced by visible light was darker and more
sustained than the pigmentation induced by UVA1 (Figure 6).
It should be noted that the UVA1 and visible light doses used
in this study are those easily obtained from daily sun
exposure. The fluence rate of the solar spectrum of visible
light, during clear sky conditions at sea level, is about 15
times higher than that of UVA. Therefore, a dose of 20 J cm2
of UVA would correspond to about 300 J cm2 of visible light
for an exposure time of about 1 hour. At 20 J cm2,
pigmentation induced by UVA1 was faint and faded rapidly
over the course of 2 weeks; on the other hand, at 320 J cm2
of visible light pigmentation was much darker and remained
unchanged until the end of the study period, which was 2
weeks (Figure 6). Thus, our results strongly suggest that visible
light could potentially have a significant role in producing
darker and longer-lasting pigmentation in populations with
skin types IV–VI than UV1 radiation.
When specifically looking for thermal and actinic DNA
damage after a single irradiation, histopathological examina-
tion of irradiated sites compared with non-irradiated control
sites showed no difference using hematoxylin and eosin, Acid
Orcein, and P53 stains. A noticeable change observed in our
histopathological examination was the redistribution of
melanin pigments, in the form of migration of melanin from
basal cells to the upper layers of the epidermis, in comparison
with the non-irradiated control sites. This redistribution
corresponds clinically to the persistent pigment darkening
seen in our volunteers 24 hours following irradiation, which
was the time when biopsies were taken.
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Figure 4. Melanin concentration. Melanin concentration as measured using
DRS at sites irradiated with visible light radiation (8–480 J cm2) and with
measurements taken immediately after irradiation (0minutes) to 2 weeks later.
Values represent the average difference between the irradiated and control
site values of 20 healthy volunteers having skin types IV–VI. Error bars denote
standard error.
a b
Figure 5. Histological changes at 24 hours after irradiation with 480 J cm2
of visible light. (a) Unirradiated control site, pigment was seen just in the
basal keratinocytes; (b) irradiated site, the circled area highlights the
redistribution of melanin pigment into the keratinocytes in the upper spinous
cell layers. Fontana-Mason stain; bar¼ 0.33mm.
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This work has implications on the use of sunscreens.
UV filters are divided into organic (also known as chemical)
and inorganic (also known as physical) filters. There is
no effective organic filter for visible light. As only optically
opaque filters are able to absorb visible light, only optically
opaque inorganic filters can protect against visible light. The
two generally available inorganic sunscreen agents are zinc
oxide and titanium dioxide (Lim and Honigsmann, 2007).
Considering that the results of this study showed that visible
light can produce sustained dark pigmentation in individuals
with skin types VI–VI, there may be a need for the
development of filters that protect against visible light. Such
filters could be useful for the management of patients with
photoaggrevated dermatoses, such as melasma.
In conclusion, this study described a method to assess
pigmentation induced by pure UVA1 and visible light, and
then applied this method to both type II and IV–VI skin. We
have also developed a visible light source that can produce
these wavelengths with minimal UV and IR contamination. A
difference exists between the quality, time course, and
duration of pigmentation produced by UVA1 and pigmenta-
tion produced by visible light. Furthermore, the response to
UVA1 and visible light irradiation depends on skin type, as
no pigmentation was induced on skin type II. Although
currently no standardized visible light source is used in all
studies, it would be ideal if such a light source could be
agreed upon and used in future studies. The fact that visible
light can induce dark and relatively sustained pigmentation
has a clinical implication on the treatment of photoderma-
toses. In addition, it shows the need for sunscreens with better
coverage in the visible light range.
MATERIALS AND METHODS
This study was reviewed and approved by the Institutional Review
Board, Henry Ford Hospital. Study procedures were followed in
accordance with the ethical standards of the Institutional Review
Board and the principles of the Helsinki Declaration of 1975.
Informed consent was obtained from all participants before the
initiation of the study.
Volunteers
To be included in the study, volunteers had to be at least 18 years
old, and not taking any photosensitizing drugs. Women who were
lactating, pregnant, or planning to become pregnant, and patients
with serious systemic disease, immunosuppression, skin cancers,
with recent history of vitiligo, melasma, other disorders of
pigmentation, and photosensitivity were excluded. The study was
conducted throughout the calendar year.
In all, 22 normal healthy volunteers were recruited, 20 of them
had Fitzpatrick skin types IV–VI (4 type IV, 12 type V, and 4 type VI)
and 2 volunteers had skin type II. Regarding gender, there were
4 males and 18 females, with a mean age of 36 years (20–60 years).
We chose the lower back as a non-sun-exposed area to conduct our
study, and a non-irradiated nearby skin site served as a control.
Volunteers were instructed to avoid sun exposure or tanning beds to
the irradiated as well as control areas during the period of the study.
Materials
Light sources and irradiation steps. We used two targeted light
sources, a UVA1 light source and a visible light source. The UVA1
light source was a Hamamatsu LightingCure UV Spot Light 200,
240–400 nm, 200W (Hamamatsu photonics K.K., Shimokanzo,
Toyooka-village, Iwata-gun, Shizuoka-ken, Japan). For irradiation
0 hours
1 day
1 week
2 weeks
UVA1
Skin type V Skin type V Skin type II
Visible light Visible light
Figure 6. Clinical photos of skin type V irradiated with UVA1 and visible light and skin type II irradiated with visible light at different time points. Cross-
polarized images of sites irradiated with UVA1 (a–d) and visible light (e–l) at different times on both type V (e–h) and type II (i–l) skin. (a, e, and i) Immediately
after irradiation, (b, f, and j) 1 day after irradiation, (c, g, and k) 1 week after irradiation, (d, h, and l) 2 weeks after irradiation.
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purposes a 9-mm Hamamatsu liquid light guide was used. The
UVA1 light source was filtered using one UV Hot Mirror/3-mm
(Newport Thin Film Laboratories, Chino, CA), UG11/1-mm, and WG
345/3-mm filter (Schott Optical Company). The light source
irradiance spectrum was measured using a calibrated Optronics
OL754 spectroradiometer (Optronics, Orlando, FL).
The visible light source used was the Fiber-Lite Model 170-D
(Dolan-Jenner Industries, Boxborough, MA) with a 150W quartz-
halogen lamp; a straight 8-mm Dolan-Jenner glass optical fiber was
used for irradiation. In all three KG5/3-mm Schott glass filters and
one GG400/3-mm (Schott Optical Company) were used to filter IR
and UV radiation from the light source, respectively. Spectral
irradiance of the visible light source was measured using a calibrated
Optronics OL750 spectroradiometer (Figure 1).
The fluence rate for both light sources was adjusted to 25 and
200mWcm2 for UVA1 and visible light, respectively, using
a calibrated Oriel Thermopile Model 71767 (Oriel, Stamford, CT).
An acrylic holder, to which the optical fibers and the liquid
light guide were attached, was specifically designed for the
study. Next, the optical fiber holder was fixed on the lower
backs of volunteers during the period of delivery of the required
doses.
The delivered ranges for the irradiation doses are shown in
Table 1. Sites were irradiated with visible light ranging from 8 J cm2
to 480 J cm2 and UVA1 from 1 J cm2 to 60 J cm2.
Clinical and instrumental assessment
Clinical and instrumental assessment for immediate pigment
darkening, persistent pigment darkening, erythema, and edema
was done at seven time points: immediately after irradiation, and
then at 30minutes, 1, 2 hours, 1 day, 1 week, and 2 weeks following
irradiation.
For each time point, cross-polarized digital photography was
used to document the exposed sites. The advantage of a cross-
polarized filter is that it prevents the glare coming from the skin
surface and thus leads to a better visualization of sub-surface
chromophores. Erythema and pigmentation were also assessed by
measuring the levels of oxy-hemoglobin and melanin, respectively,
using DRS. Biopsies were carried out at sites exposed to the highest
visible light dose used at 24 hours; biopsies from an unexposed
surrounding site served as control specimens.
Diffuse reflectance spectroscopy. DRS is an analytical tool used
to investigate the optical properties of an absorbed molecule, and to
measure the scattering and absorption properties of the skin in which
a beam of light penetrates. The DRS instrument consisted of a quartz
halogen light source (Ocean Optics, Boca Raton, FL), a bifurcated
fiber bundle (Multimode Fiber Optics, East Hanover, NJ), an S2000
spectrometer (Ocean Optics), and a laptop computer. Before data
acquisition, the spectrophotometer was calibrated using pure white
tile and a dark background for compensation. Apparent concentra-
tions of hemoglobin and melanin were calculated from the diffuse
reflectance spectra as described by Kollias et al. (1992). Measure-
ments were taken from the irradiated site and the adjacent
unirradiated control site. In order to calculate the changes in the
chromophore concentrations, the value for the control site was
subtracted from that for the irradiated site. Therefore, if there is no
detectable change in the irradiated site, the value would be
zero. Based on clinical correlation, the threshold for minimal
perceptible erythema that correlated with DRS measurements
was 0.45 in terms of relative difference in absorbance values
(irradiated minus control sites).
Confocal microscopy. Pigmentation induced by the highest dose
of UVA1 and visible light as well as the control site was then
assessed using a hand-held confocal microscope (VivaScope 3000,
Lucid, Rochester, NY) designed specifically for clinical imaging of
the skin, at 2 and 24 hours after the highest dose of visible light
irradiation.
Statistical analysis
DRS measurements were taken in triplicate with the 2.5-mm-
diameter fiber on the irradiated as well as control skin sites. The
results were presented as means and standard deviation; standard
least square statistical model analysis was carried out using JMP 7
(SAS Institute, Cary, NC).
Histopathology and immunohistochemistry
Histological changes induced by the highest dose of visible light
were assessed by histopathological examination 24 hours after
irradiation, for the irradiated site and for the non-irradiated area
(control) using hematoxylin and eosin, Fontana-Masson, AcidOr-
cein, and P53 stains.
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